|
| (i) Pharmaceutical interventions | |
| (medications that may provide symptom relief for cognitive, emotional, and behavioral issues) | |
| Donepezil | |
| Rivastigmine | |
| Galantamine | |
| Memantine | |
| Psychotropic (antidepressants, antianxiety, mood stabilizer, antipsychotic) | |
| (ii) Nutraceutical interventions | |
| (dietary supplements still in research stages) | |
| Omega 3 | |
| Curcumin | |
| Vitamin D | |
| Alpha GPC | |
| Phosphatidylserine | |
| Choline | |
| (iii) Medical foods interventions | |
| (prescriptive) | |
| Axona | |
| CerefolinNAC | |
| Souvenaid (not currently available in the USA) | |
| (iv) Neurophysiological interventions | |
| (still in research stages) | |
| Cranioelectric stimulation | |
| Transcranial magnetic stimulation | |
| Neurofeedback | |
| Laser light therapy | |
| (v) Physical health interventions | |
| Aerobic exercise | |
| Medical management of disease | |
| Diabetes | |
| Hypertension | |
| Hyperlipidemia | |
| (vi) Cognitive interventions | |
| Mental exercises/hobbies | |
| Compensatory memory strategies and aids | |
| Cognitive training | |
| (vii) Behavioral interventions | |
| (strategies to manage factors such as wandering, sundowning, agitation, disorientation, affective disinhibition, stubbornness, paranoia, irritability, apathy, and restlessness) | |
| Occupational therapy safety assessment of home | |
| Low stress calming environment | |
| Regular sleep and meal schedules | |
| Redirection and distraction | |
| Minimization of unexpected changes in environment | |
| Patient counseling and support groups in early stages | |
| Caregiver strategies and resources through support groups and internet | |
| In-home aide/assistant | |
| Outpatient day program with all inclusive care | |
| assisted living facility | |
| (viii) Future planning interventions | |
| Caregiver counseling to aid in life planning and decision making | |
| Legal services for guardianship and capacity | |
| Financial advisor for estate planning | |
|
